Brian J. Aneskievich
Professor/Pharmaceutical Science

Are you Brian J. Aneskievich?

How to update your information.
Grants

43 Grants

Small Molecule Regulation of a Repressor of Psoriatic Inflammation
Sponsor: National Psoriasis Foundation
Authors: Brian J Aneskievich
2023-08-01 - 2024-07-31
Assessing the Role of Conformational Flexibility in the Anti-Inflammatory Protein TNIP1
Sponsor: American Foundation for Pharmaceutical Education
Authors: Brian J Aneskievich
2019-09-01 - 2020-08-31
Subproject for Institution # 120718
Sponsor: NSF/National Science Foundation/University of Connecticut Health Center
Authors: Brian J Aneskievich
2013-06-01 - 2018-05-31
Regulating Self-Renewal Versus Initiation of Terminal Differentiation of Human Skin Stem Cells
Sponsor: CT Department of Public Health
Authors: Brian J Aneskievich
2013-09-01 - 2015-08-31
Integrated Investigation of a Transcriptional Repressor's Role in Nuclear Receptor and NF-kappaB Signaling
Sponsor: American Foundation for Pharmaceutical Education
Authors: Brian J Aneskievich
2010-09-01 - 2011-08-31
Assessing Biomolecular Protein Condensates as Sites for Restricting Cytoplasmic Progression of Signaling in Chronic Inflammatory Diseases
Sponsor: American Foundation for Pharmaceutical Education
Authors: Brian J Aneskievich
2025-09-01 - 2026-08-31
Repression of Lupus Inflammatory Signals
Sponsor: DOD/Department of Defense
Authors: Brian J Aneskievich
2019-09-01 - 2020-08-31
Elucidating the Consequences of Structural Fluidity in the Function of the Anti-Inflammatory Protein TNIP1
Sponsor: American Foundation for Pharmaceutical Education
Authors: Brian J Aneskievich
2018-09-01 - 2019-08-31
Keratinocyte Assessment of Psoriasis-Associated TNIP1
Sponsor: National Psoriasis Foundation
Authors: Brian J Aneskievich
2015-07-01 - 2016-06-30
TNIP1 Role in Keratinocyte Growth and Differentiation
Sponsor: DHHS/NIH/National Institutes of Health
Authors: Brian J Aneskievich
2016-04-01 - 2021-03-31
Identification and Assessment of Anti-fibroinflammatory Ligands for Development of Novel Scleroderma Therapeutics
Sponsor: DHHS/NIH/National Institutes of Health
Authors: Brian J Aneskievich
2025-12-01 - 2027-11-30
Control Over Pro-Fibrotic Signaling by the Scleroderma-Associated Gene TNIP1
Sponsor: DOD/Department of Defense
Authors: Brian J Aneskievich
2018-09-01 - 2021-08-31
TNIP1 Role in Keratinocyte Growth and Differentiation
Sponsor: DHHS/NIH/National Institutes of Health
Authors: Brian J Aneskievich
2015-07-01 - 2020-06-30
Heat Shock A1A and A6 are Transcriptionally Controlled by the Novel Nuclear Receptor Coregulator TNIP1
Sponsor: American Foundation for Pharmaceutical Education
Authors: Brian J Aneskievich
2011-09-01 - 2012-08-31
TNIP1 Protein Functional Diversity as a Repressor of Distinct Signaling Pathways
Sponsor: NSF/National Science Foundation
Authors: Brian J Aneskievich
2017-08-01 - 2020-07-31
Rational Formulations and Pre-Clinical Assessments for Improved Therapeutic Peptide Delivery
Sponsor: DHHS/NIH/National Institutes of Health
Authors: Brian J Aneskievich
2016-07-01 - 2018-06-30
Keratinocyte Nuclear Receptor Coactivators
Sponsor: DHHS/NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Authors: Brian J Aneskievich
2013-09-01 - 2018-08-31
Control of Post-Receptor Signaling in the Balance of Stem, Amplifying and Differentiating Keratinocytes
Sponsor: CT Department of Public Health
Authors: Brian J Aneskievich
2014-09-01 - 2016-08-31
Transcriptional Regulation of a Novel Nuclear Receptor Coregulator
Sponsor: American Foundation for Pharmaceutical Education
Authors: Brian J Aneskievich
2009-09-01 - 2012-08-31
Regulation of Post-Receptor Signaling in Balancing Epidermal Regeneration and Differentiation
Sponsor: Connecticut Innovations
Authors: Brian J Aneskievich
2016-09-01 - 2020-08-31